Celanese Corporation reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2015. For the quarter, the company reported net sales of $1,334 million compared to $1,559 million a year ago. Operating loss was $305 million compared to $54 million a year ago. Loss from continuing operations before tax was $270 million compared to $31 million a year ago. Net loss was $301 million compared to $85 million a year ago. Net loss attributable to the company was $298 million compared to $84 million a year ago. Basic and diluted net loss per share was $2.03 compared to $0.55 a year ago. Capex was $62 million for the quarter. Adjusted earnings per share were $1.25, down 2% from prior year. Operating EBITDA was $332 million compared to $375 million a year ago. Loss from continuing operations was $301 million compared to $83 million a year ago. Net loss attributable to the company from continuing operations was $298 million compared to $82 million a year ago. Basic and diluted net loss per share from continuing operations was $2.03 compared to $0.54 a year ago.

For the full year, the company reported net sales of $5,674 million compared to $6,802 million a year ago. Operating profit was $326 million compared to $758 million a year ago. Earnings from continuing operations before tax was $488 million compared to $941 million a year ago. Earnings from continuing operations were $287 million compared to $627 million a year ago. Net earnings were $285 million compared to $620 million a year ago. Net earnings attributable to the company were $304 million compared to $624 million a year ago. Diluted net income per share was $2.00 compared to $4.00 a year ago. Free cash flow was $733 million before including the impact of a cash payment related to terminating a supply contract. Capex for the year was $306 million. Adjusted earnings per share of $6.02, up 6% from prior year, driven by the strength of commercial models in both the Acetyl Chain and Materials Solutions. Operating EBITDA was $1,515 million compared to $1,558 million a year ago. Net earnings attributable to the company from continuing operations were $306 million compared to $631 million a year ago. Diluted net loss per share from continuing operations was $2.01 compared to $4.04 a year ago. EBIT margin was 21.8%.

The company anticipates adjusted earnings per share to grow 5% to 10% in 2016 which will keep well on track to meet the 2018 targets. The company expected normal range to be more of the $250 million to $300 million of capital spend going forward.

For the fourth quarter, the company announced the asset impairment loss of $123 million related to a write-off of ethanol assets at integrated facility in Nanjing, China.